نتائج البحث 121-130 من 2088 لعملية البحث عن anti-TNF drugs
Drugs such as sapanisertib may stop the growth or ... Anti-cancer activity will be assessed every 6 ... This study will compare the use of hypofraction proton ...
Monoclonal antibody drugs for cancer treatment How they work. عطاؤك له أثر كبير — تبرَّع الآن! تبرَّع. تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر ...
Drugs used in chemotherapy, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth ...
This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...
Obesity treatment: A focus on pharmacotherapy of weight management. 2020; doi:10.1097/NOR.0000000000000643. Papadakis MA, et al., eds. Obesity. In: Current ...
U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-safety-and-availability/fda-releases-important-information-about-risk-covid-19-due-certain- ...
The median survival of patients with LM with treatment is generally less than 5 months. There are four FDA-approved drugs for intra-CSF use in LM, but all ...
Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. Establishment of Preclinical Models from Patients with ...
... drug therapy against pulmonary mycobacterium avium complex (MAC) disease, and whether 2-drug therapy is better tolerated than 3-drug therapy. A Study to ...
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.